Browsing Tag: LYNKUET elinzanetant breast cancer symptoms

Bayer’s LYNKUET (elinzanetant) receives expanded authorization in Canada for breast cancer-related vasomotor symptoms Bayer Canada announced that Health Canada has expanded the market authorizat...